MFMélanie Fortin

Mélanie Fortin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mélanie Fortin has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Andre C. Carpentier

    Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada

    2 shared publications
  • Christophe Noll

    Division of Endocrinology, Department of Medicine, Centre de recherche du CHUS, Université de Sherbrooke, Sherbrooke, Quebec, Canada

    2 shared publications
  • Brigitte Guérin

    Department of Nuclear Medicine and Radiobiology, Centre de Recherche du CHUS, Université de Sherbrooke, Quebec, Canada

    1 shared publication
  • Dany Dion

    Division of Endocrinology, Department of Medicine, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke , Sherbrooke, QC J1H 5N4

    1 shared publication
  • Emilie Montastier

    Institute of Metabolic and Cardiovascular Diseases, I2MC, UMR1297, Inserm, Toulouse III - Paul Sabatier University, Toulouse, France. Toulouse University Hospital, Toulouse, France

    1 shared publication
  • Eric E. Turcotte

    Department of Nuclear Medicine and Radiobiology, Centre de Recherche du CHUS, Université de Sherbrooke, Quebec, Canada

    1 shared publication

Latest Publications

  • Open Access

    Nicotinic acid increases adipose tissue dietary fatty acid trapping and reduces postprandial hepatic and cardiac fatty acid uptake in prediabetes

    by Émilie Montastier, Run Zhou Ye, Christophe Noll, Mehdi Amrani, Frédérique Frisch, Mélanie Fortin, Lucie Bouffard, Serge Phoenix, Otman Sarrhini, Stephen C. Cunnane, et al.


  • Open Access

    Plasma Endocannabinoids Are Independently Associated With the Metabolic Function of White Adipose Tissue

    by Dany Dion, Christophe Noll, Mélanie Fortin, Lounès Haroune, Sabrina Saibi, Philippe Sarret, André C Carpentier

    Context Little is known about the link between the endocannabinoid system and the in vivo metabolic function of white adipose tissue (WAT). Objective We aimed to evaluate whether endocannabinoids (EC) are linked to postprandial fatty acid metabolism and WAT metabolic function. Design Men and women, with (IGT, n=20) or without impaired glucose tolerance (NGT, n=20) underwent meal testing with oral and intravenous stable isotope palmitate tracers and positron emission tomography with intravenous [11C]-palmitate and oral [18F]-fluoro-thia-heptadecanoic acid to determine systemic and organ-specific dietary fatty acid (DFA) and non-esterified fatty acid (NEFA) metabolism and partitioning. We determined fasting and postprandial plasma levels of EC by UHPLC-MS/MS. Results All EC of the 2-monoacylglycerol (2-MAG) family displayed a progressive postprandial increase up to 360 min after meal intake that was more pronounced in women with IGT. N-acylethanolamine (NAE) levels decreased between fasting and 180 min, followed by a return to pre-prandial values at 360 min and were also increased in women with IGT. Postprandial area under the curve (AUC) of palmitate appearance rate was significantly and independently associated with postprandial AUC of anandamide (AEA; P=0.0003) and total energy expenditure (P=0.0009). DFA storage in abdominal subcutaneous adipose tissue was positively predicted by fasting 2-arachidonoylglycerol (2-AG; P<0.04). Conclusion EC levels of the NAE family independently follow plasma NEFA metabolism, whereas 2-MAG closely follow the spillover of triglyceride-rich lipoprotein intravascular lipolytic products. Whether these associations are causal requires further investigation.